title: BioBanking - The Holy Grail of novel drug and diagnostic developments?
abstract: The ever increasing social cost that society pays for illness and disease are currently steadily increasing in many countries in the world today. These changes in society becomes a major financial burden that activates politicians and health care organizations in order to find new solutions. Biobanks are becoming the new powerful modality within the field of modern Life Science, that is expected to be important in the proactive awareness of patient health status. Biobanks are also expected to promote the developments of targeted treatments with personalized indicator assays, for effective use of Personalized Medicine treatments in the near future.
authors: Div, Clinical Protein Science & Imaging, Dept, of Measurement Technology and Industrial Electrical Engineering, Lund University Biomedical Center, BMC C13 SE-221 84 Lund, Sweden. Gyorgy.Marko-Varga@elmat.lth.se.
authors: György
authors: G
authors: Marko-Varga